Committee RDF
pages:- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- more...
- CTSA Consortium Steering Committee
- CTSA Consortium Steering Committee (National CTSA Consortium)
- CTSA Executive Committee
- CTSA Executive Committee
- CTSA K Advisory Committee
- CTSA Operations Group, and its Strategic Planning Committee
- CTSA Steering Committee
- CTSA T Advisory Committee
- CTSB Project Management Team (University of Rochester)
- CTSI Community Engagement Program
- CTSI Executive Committee (University of Rochester)
- CTSI Executive Operations Committee
- Curriculum Committee
- Curriculum Committee
- Curriculum Committee (Department of Epidemiology)
- Curriculum Committee (Joint University of Arkansas at Little Rock/University of Arkansas for Medical Sciences Training Program in Bioinformatics)
- Curriculum Committee (Joint University of Arkansas at Little Rock/University of Arkansas for Medical Sciences Training Program in Bioinformatics)
- Curriculum Committee - Santa Fe Community College and UF College of Liberal Arts and Sciences
- Curriculum Committee of the Course of Preventive Medicine
- Curriculum Committee, Department of Epidemiology & Health Policy Research, College of Medicine, University of Florida
- Curriculum Planning Committee for Revision of Special Education
- Data and Analytics Implementation committee of UF Health
- Data and Analytics Strategic Planning committee of UF Health
- Data Governance Committee
- Data Management Coordinating Committee (DMCC)
- Data Safety and Monitoring Board (CLEVER Trial)
- Data Safety and Monitoring Board for the randomized trial to examine the effects of lowering serum uric acid on the incidence of postoperative acute kidney injury
- Data Safety and Monitoring Board for the trial on Uric Acid and Hypertension in African-Americans
- Data Safety and Monitoring Board, Acute Lymphoblastic Leukemia Clinical Trial, Pfizer
- Data Safety and Monitoring Board, Acute Lymphoblastic Leukemia Trial, Novartis